Investing
Cathie Wood's ARK Invest Sells Over 60,000 Shares of Pluristem Therapeutics
Published:
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 62,000 shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) on Tuesday, as the share price of this fund traded up less than 1% in the day’s session. That share price has greatly improved over the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 62,738 shares of Pluristem. At Tuesday’s closing price, this would have valued this sale at roughly $252,000. This is only a small fraction of the total holdings. This fund is up 84% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKG | CSTL | Castle Biosciences | 4,800 |
| ARKG | PSTI | Pluristem Therapeutics | 62,738 |
| ARKQ | GLEO | Galileo Acquisition | 1,798 |
| ARKQ | RAVN | Raven Industries | 8,104 |
| ARKW | LC | LendingClub | 82 |
| ARKW | PD | PagerDuty | 6,567 |
| ARKW | ROKU | Roku | 5,986 |
| ARKW | SE | Sea | 21,337 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
